Showing results (131-140 of 188) with videos related to
Sort By:
Pageof 19
Journal of Pain and Symptom Management|September 26, 2021
Caregivers' Death-Preparedness States Impact Caregiving Outcomes and Patients' End-of-Life CareFur-Hsing Wen, Wen-Chi Chou, Ming-Mo Hou, et al.Psycho-Oncology|September 22, 2021
Associations of death-preparedness states with bereavement outcomes for family caregivers of terminally ill cancer patientsFur-Hsing Wen, Wen-Chi Chou, Ming-Mo Hou, et al.Medicine|October 19, 2019
Merkel cell carcinoma in Taiwan: A series of 24 cases and literature reviewJohn Wen-Cheng Chang, Yao-Yu Chang, Yen-Lin Huang, et al.Life (Basel, Switzerland)|November 11, 2020
Chromosomal Instability May Not Be a Predictor for Immune Checkpoint Inhibitors from a Comprehensive Bioinformatics AnalysisChiao-En Wu, Da-Wei Yeh, Yi-Ru Pan, et al.JAMA Network Open|September 1, 2020
Type of Androgen Deprivation Therapy and Risk of Dementia Among Patients With Prostate Cancer in TaiwanWen-Kuan Huang, Chi-Hung Liu, See-Tong Pang, et al.Anticancer Research|March 29, 2022
Real-world Afatinib Outcomes in Advanced Non-small Cell Lung Cancer Harboring EGFR MutationsChi-Han Chen, John Wen-Cheng Chang, Ching-Fu Chang, et al.Cancers|October 27, 2022
Impact of T790M Mutation Status on Later-Line Osimertinib Treatment in Non-Small Cell Lung Cancer PatientsYan-Jei Tang, John Wen-Cheng Chang, Ching-Fu Chang, et al.Thoracic Cancer|August 1, 2023
Comprehensive assessment of pretreatment sarcopenia impacts on patients with EGFR-mutated NSCLC treated with afatinibChen-Te Wu, Ping-Chih Hsu, John Wen-Cheng Chang, et al.Acta Radiologica (Stockholm, Sweden : 1987)|November 20, 2019
Response evaluation for immunotherapy through semi-automatic software based on RECIST 1.1, irRC, and iRECIST criteria: comparison with subjective assessmentYing-Chieh Lai, Wen-Cheng Chang, Chun-Bing Chen, et al.Asia-Pacific Journal of Clinical Oncology|August 5, 2016
A comparison of immunohistochemical and molecular methods used for analyzing the BRAF V600E gene mutation in malignant melanoma in TaiwanWen-Kuan Huang, Tseng-Tong Kuo, Chiao-En Wu, et al.Pageof 19